on August 19, 2002
Circulation. 2002
Published online before print August 19, 2002, doi: 10.1161/01.CIR.0000028146.71416.2E
Published online before print August 19, 2002, doi: 10.1161/01.CIR.0000028146.71416.2E
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 27, 2002
From the Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio. * To whom correspondence should be addressed. E-mail: elliss{at}ccf.org.
Background—Creatine kinase (CK)-MB elevation after percutaneous coronary intervention (PCI) has been associated with subsequent cardiac death. The patients at risk, the timing of risk, and potential treatment implications are uncertain. Methods and Results—Eight thousand, four hundred nine consecutive non Conclusions—Patients with CK-MB elevation after PCI are at excess risk of death for 3 to 4 months, although prolonging hospitalization for CK-MB 1 to 5x is unlikely to modify risk. CK-MB >5x normal, incomplete revascularization, elevated C-reactive protein, heart failure, the elderly, and hospital discharge without on statin therapy increases risk. Several of these factors suggest that inflammation may play a part in the excess risk of death.
Revised on June 18, 2002
Accepted on June 18, 2002
Death Following Creatine Kinase-MB Elevation After Coronary Intervention. Identification of an Early Risk Period: Importance of Creatine Kinase-MB Level, Completeness of Revascularization, Ventricular Function, and Probable Benefit of Statin Therapy
Stephen G. Ellis MD*,
acute myocardial infarction patients with successful PCI and no emergency surgery or Q-wave myocardial infarction were followed for 38±25 months; 1446 (17.2%) had post-PCI CK-MB above normal on routine ascertainment. Patients were prospectively stratified into those with CK-MB 1 to 5x or CK-MB >5x normal. No patient with CK-MB 1 to 5x normal died during the first week after PCI, and excess risk of early death for patients with CK-MB elevation occurred primarily in the first 3 to 4 months. The actuarial 4-month risk of death was 8.9%, 1.9%, and 1.2% for patients with CK-MB >5x, CK-MB 1 to 5x, and CK-MB 
1x normal (P<0.001). Death within 4 months was independently correlated with the degree of CK-MB elevation, creatinine 
2 mg%, post-PCI C-reactive protein, low ejection fraction, age, and congestive heart failure class (P<0.01 for all). In a matched subset analysis, incomplete revascularization (P<0.001), congestive heart failure class (P=0.005), and no statin treatment at hospital discharge (P=0.009) were associated with death.
Key words: angioplasty • myocardial infarction • proteins
This article has been cited by other articles:
 |
|
 |
|
  A Kumar and D H Roberts Immediate versus deferred coronary angioplasty in non-ST-elevation acute coronary syndromes Heart, September 1, 2009; 95(17): 1455 - 1456. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Briguori, G. Visconti, A. Focaccio, B. Golia, A. Chieffo, A. Castelli, M. Mussardo, M. Montorfano, B. Ricciardelli, and A. Colombo Novel Approaches for Preventing or Limiting Events (Naples) II Trial: Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction J. Am. Coll. Cardiol., August 5, 2009; (2009) j.jacc.2009.07.005v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Prasad, B. J. Gersh, M. E. Bertrand, A. M. Lincoff, J. W. Moses, E. M. Ohman, H. D. White, S. J. Pocock, B. T. McLaurin, D. A. Cox, et al. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J. Am. Coll. Cardiol., July 28, 2009; 54(5): 477 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Testa, W.J. Van Gaal, G.G.L. Biondi Zoccai, P. Agostoni, R.A. Latini, F. Bedogni, I. Porto, and A.P. Banning Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition QJM, June 1, 2009; 102(6): 369 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Prasad, C. S. Rihal, R. J. Lennon, M. Singh, A. S. Jaffe, and D. R. Holmes Jr Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary Intervention: An Analysis of Preintervention and Postintervention Troponin T Levels in 5487 Patients Circ Cardiovasc Interv, August 1, 2008; 1(1): 10 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Routledge, M.-C. Morice, T. Lefevre, P. Garot, F. De Marco, B. Vaquerizo, and Y. Louvard 2-Year Outcome of Patients Treated for Bifurcation Coronary Disease With Provisional Side Branch T-Stenting Using Drug-Eluting Stents J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 358 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Stone, J. H. Ware, M. E. Bertrand, A. M. Lincoff, J. W. Moses, E. M. Ohman, H. D. White, F. Feit, A. Colombo, B. T. McLaurin, et al. Antithrombotic Strategies in Patients With Acute Coronary Syndromes Undergoing Early Invasive Management: One-Year Results From the ACUITY Trial JAMA, December 5, 2007; 298(21): 2497 - 2506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Cutlip, S. Windecker, R. Mehran, A. Boam, D. J. Cohen, G.-A. van Es, P. Gabriel Steg, M.-a. Morel, L. Mauri, P. Vranckx, et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions Circulation, May 1, 2007; 115(17): 2344 - 2351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Prasad, M. Singh, A. Lerman, R. J. Lennon, D. R. Holmes Jr, and C. S. Rihal Isolated Elevation in Troponin T After Percutaneous Coronary Intervention Is Associated With Higher Long-Term Mortality J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1765 - 1770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Boodhwani and F. W. Sellke Myometrium: another candidate for cell-based myocardial angiogenesis Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2039 - H2040. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Groschel, U. Ernemann, J. B. Schulz, T. Nagele, C. Terborg, and A. Kastrup Statin Therapy at Carotid Angioplasty and Stent Placement: Effect on Procedure-related Stroke, Myocardial Infarction, and Death. Radiology, July 1, 2006; 240(1): 145 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P J Bradshaw, D T Ko, A M Newman, L R Donovan, and J V Tu Validity of the GRACE (Global Registry of Acute Coronary Events) acute coronary syndrome prediction model for six month post-discharge death in an independent data set Heart, July 1, 2006; 92(7): 905 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Kereiakes and D. P. Faxon Left Main Coronary Revascularization at the Crossroads Circulation, May 30, 2006; 113(21): 2480 - 2484. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kuduvalli, N. Newall, A. Stott, A. D. Grayson, and B. M. Fabri Impact of avoiding cardiopulmonary bypass for coronary surgery on perioperative cardiac enzyme release and survival. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 729 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Herrmann Peri-procedural myocardial injury: 2005 update Eur. Heart J., December 1, 2005; 26(23): 2493 - 2519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zimarino, A. M. Calafiore, and R. De Caterina Complete myocardial revascularization: between myth and reality Eur. Heart J., September 2, 2005; 26(18): 1824 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Cutlip and R. E. Kuntz Cardiac Enzyme Elevation After Successful Percutaneous Coronary Intervention Is Not an Independent Predictor of Adverse Outcomes Circulation, August 9, 2005; 112(6): 916 - 923. [Full Text] [PDF]
|
|
|
|
|
|
C. Cavallini, S. Savonitto, R. Violini, G. Arraiz, M. Plebani, Z. Olivari, P. Rubartelli, S. Battaglia, L. Niccoli, G. Steffenino, et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study Eur. Heart J., August 1, 2005; 26(15): 1494 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Patti, G. Colonna, V. Pasceri, L. L. Pepe, A. Montinaro, and G. Di Sciascio Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study Circulation, April 26, 2005; 111(16): 2099 - 2106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Gurbel, K. P. Bliden, K. A. Zaman, J. A. Yoho, K. M. Hayes, and U. S. Tantry Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets: Results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) Study Circulation, March 8, 2005; 111(9): 1153 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Briguori, A. Colombo, F. Airoldi, A. Violante, A. Focaccio, P. Balestrieri, P. Paolo Elia, B. Golia, S. Lepore, G. Riviezzo, et al. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction Eur. Heart J., October 2, 2004; 25(20): 1822 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jeremias, D. S. Baim, K. K.L. Ho, M. Chauhan, J. P. Carrozza Jr, D. J. Cohen, J. J. Popma, R. E. Kuntz, and D. E. Cutlip Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1210 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Pasceri, G. Patti, A. Nusca, C. Pristipino, G. Richichi, G. Di Sciascio, and on behalf of the ARMYDA Investigators Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study Circulation, August 10, 2004; 110(6): 674 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Singh, C. S. Rihal, R. J. Lennon, K. N. Garratt, and D. R. Holmes Jr Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions J. Am. Coll. Cardiol., July 21, 2004; 44(2): 357 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G Katritsis Elevation of CK-MB following percutaneous coronary intervention Eur. Heart J., July 1, 2004; 25(13): 1180 - 1180. [Full Text] [PDF]
|
|
|
|
|
|
K A A Fox, J Birkhead, R Wilcox, C Knight, and J Barth British Cardiac Society Working Group on the definition of myocardial infarction Heart, June 1, 2004; 90(6): 603 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.T. Roe, K.W. Mahaffey, R. Kilaru, J.H. Alexander, K.M. Akkerhuis, M.L. Simoons, R.A. Harrington, B.E. Tardiff, C.B. Granger, E.M. Ohman, et al. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes Eur. Heart J., February 2, 2004; 25(4): 313 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Iakovou, G. S. Mintz, G. Dangas, A. Abizaid, R. Mehran, Y. Kobayashi, A. J. Lansky, E. D. Aymong, E. Nikolsky, G. W. Stone, et al. Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1900 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone, D. A. Cox, J. Babb, D. Nukta, L. Bilodeau, L. Cannon, T. D. Stuckey, J. Hermiller, E. A. Cohen, R. Low, et al. Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries J. Am. Coll. Cardiol., December 3, 2003; 42(11): 2007 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. A. Ioannidis, E. Karvouni, and D. G. Katritsis Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1406 - 1411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Nallamothu and E. R. Bates Periprocedural myocardial infarction and mortality: Causality versus association J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1412 - 1414. [Full Text] [PDF]
|
|
|
|
|
|
J. R. Kizer, M. R. Muttrej, W. H. Matthai, J. McConnell, H. Nardone, A. F. Sonel, M. G. Keane, and R. L. Wilensky Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention Eur. Heart J., July 2, 2003; 24(14): 1314 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. W. Wang, A. Osman, J. Otero, G. A. Stouffer, S. Waxman, A. Afzal, A. Anzuini, and B. F. Uretsky Distal Myocardial Protection During Percutaneous Coronary Intervention With an Intracoronary {beta}-Blocker Circulation, June 17, 2003; 107(23): 2914 - 2919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Prati, T. Pawlowski, R. Gil, A. Labellarte, A. Gziut, E. Caradonna, A. Manzoli, A. Pappalardo, F. Burzotta, and A. Boccanelli Stenting of Culprit Lesions in Unstable Angina Leads to a Marked Reduction in Plaque Burden: A Major Role of Plaque Embolization?: A Serial Intravascular Ultrasound Study Circulation, May 13, 2003; 107(18): 2320 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Palinski and C. Napoli Unraveling Pleiotropic Effects of Statins on Plaque Rupture Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1745 - 1750. [Full Text] [PDF]
|
|
|
|
 |
|
 Periprocedural CK-MB Elevation Associated with Early Post-PCI Mortality Journal Watch Cardiology, November 1, 2002; 2002(1101): 2 - 2. [Full Text]
|
|